Management of Treatment-Resistant Major Psychiatric Disorders

1. Auflage 2012
ISBN: 978-0-19-973998-1
Verlag: Oxford University Press

Buch, Englisch, 400 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 908 g

• Covers all major treatment-resistant psychiatric disorders in one book for the first time
• Summarizes essential information in easy-to-digest tables throughout the volume
• Explains in detail pharmacologic, non-pharmacologic and somatic interventions

Although there are a variety of textbooks and manuals of psychiatric disorders, few have focused on the management of treatment-resistant patients. Those that exist have largely focused on treatment-resistant depression and even these are now largely outdated. Because psychiatrists and other mental health care professionals increasingly manage patients who fail treatment from family practitioners and other non-psychiatric specialists, a single practical volume summarizing the evidence-based medicine as well as the art of managing treatment-resistant patients is a much needed volume for practitioners, psychiatry residents and other mental health workers. Most importantly, both psychopharmacological and psychotherapeutic interventions will be included, a shortcoming of many previous volumes.

"Management of Treatment Resistant Major Psychiatric Disorders" contains chapters authored by leaders in the field on the management of the major treatment resistant psychiatric disorders.

Zielgruppe

Psychiatrists, Psychiatric residents and fellows, Clinical psychologists, other mental health practitioners

Autoren/Hrsg.

Nemeroff, Charles B

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Psychiatrie, Sozialpsychiatrie, Suchttherapie
• Sozialwissenschaften Psychologie Psychotherapie / Klinische Psychologie

Inhaltsverzeichnis

Chapter 1. The Problem of Treatment-Resistant Major Psychiatric Disorders
Charles B. Nemeroff and Patricio Riva Posse
Chapter 2. Management of Treatment-Resistant Depression: Psychopharmacology and Psychotherapy
Michael E. Thase and K. Ryan Connolly
Chapter 3. Management of Treatment-Resistant Depression - Somatic-Non-pharmacological Strategies
Paul E. Holtzheimer
Chapter 4. Management of Treatment-Resistant Bipolar Disorder
Mark A. Frye
Chapter 5. Management of Treatment-Resistant Panic Disorder
Robert Bruce Lydiard
Chapter 6. Management of Treatment-Resistant Post-Traumatic Stress
Disorder
Dan J. Stein and Kerry-Ann Louw
Chapter 7. Management of Treatment-Resistant Social Anxiety Disorder
Eric Bui and Mark H. Pollack
Chapter 8. Management of Treatment-Resistant Generalized Anxiety Disorder
Victoria Osman-Hicks, John Potokar, and David J. Nutt
Chapter 9. Management of Treatment-Resistant Obsessive-Compulsive Disorder
Robert Hudak, Priya Gopalan, and Darin D. Dougherty
Chapter 10. Management of Treatment-Resistant Anorexia Nervosa
Enrica Marzola, Mary Ellen Trunko, Emily Grenesko-Stevens and Walter H. Kaye
Chapter 11. Management of Treatment-Resistant Schizophrenia
Jacob S. Ballon and Jeffrey A. Lieberman
Chapter 12. Management of Treatment-Resistant Substance and Alcohol Abuse
Kathleen T. Brady
Chapter 13. Management of Treatment-Resistant Personality Disorders
Glen O. Gabbard
Chapter 14. Management of Treatment-Resistant Insomnia
Karl Doghramji and Charles F. Reynolds III
Chapter 15. Management of Treatment-Resistant Childhood Disorders
Karen Dineen Wagner

Über Autor(innen)

Nemeroff, Charles B
Dr. Nemeroff's research has concentrated on the biological basis of the major neuropsychiatric disorders, including affective disorders, schizophrenia, and anxiety disorders. His clinical research is focused on the use of genetic, neuroendocrine, neuroimaging and neurochemical methods to comprehensively understand the pathophysiology of depression. In recent years he has uncovered the neurobiological mechanisms that mediate the increased risk for depression in victims of child abuse. He has also contributed to seminal findings in the burgeoning area of research concerning the relationship of depression to cardiovascular disease.

Dr. Nemeroff's research has concentrated on the biological basis of the major neuropsychiatric disorders, including affective disorders, schizophrenia, and anxiety disorders. His clinical research is focused on the use of genetic, neuroendocrine, neuroimaging and neurochemical methods to comprehensively understand the pathophysiology of depression. In recent years he has uncovered the neurobiological mechanisms that mediate the increased risk for depression in victims of child abuse. He has also contributed to seminal findings in the burgeoning area of research concerning the relationship of depression to cardiovascular disease.

Contributors:
Jacob S. Ballon, MD
Department of Psychiatry
College of Physicians and Surgeons
Columbia University; and
New York State Psychiatric Institute
New York, NY

Kathleen T. Brady, MD, PhD
Department of Psychiatry
Clinical Neuroscience Division
Clinical and Translational Research
South Carolina Clinical and Translational Research Institute; and
Medical University of South Carolina
Charleston, SC

Eric Bui, MD, PhD
Department of Psychiatry
Massachusetts General Hospital
Boston, MA

K. Ryan Connolly, MD
Department of Psychiatry
University of Pennsylvania School of Medicine
Philadelphia, PA

Karl Doghramji, MD
Departments of Psychiatry and Neurology; and
Sleep Disorders Center
Thomas Jefferson University
Philadelphia, PA

Darin D. Dougherty, MD
Department of Psychiatry
Massachusetts General Hospital
Boston, MA

Mark A. Frye, MD
Department of Psychiatry and Psychology
Mayo Clinic
Rochester, MN

Glen O. Gabbard, MD
Department of Psychiatry
Baylor College of Medicine
Houston, TX

Priya Gopalan, MD
Department of Psychiatry
Western Psychiatric Institute and Clinic
Pittsburgh, PA

Emily Grenesko-Stevens
Department of Psychiatry
University of California-San Diego, CA

Paul E. Holtzheimer, MD
Department of Psychiatry
Dartmouth-Hitchcock Medical Center
Lebanon, NH

Robert Hudak, MD
Department of Psychiatry
Western Psychiatric Institute and Clinic
Pittsburgh, PA

Walter H. Kaye, MD
Department of Psychiatry
University of California-San Diego, CA

Jeffrey A. Lieberman, MD
Department of Psychiatry
Columbia University College of Physicians and Surgeons; and
New York State Psychiatric Institute; and
New York Presbyterian Hospital-Columbia University Medical Center
New York, NY

Kerry-Ann Louw, MB ChB
Department of Psychiatry and Mental Health
University of Cape Town
South Africa

Robert Bruce Lydiard, MD, PhD
Department of Psychiatry and Behavioral Sciences
Medical University of South Carolina
Charleston, SC

Enrica Marzola, MD
Department of Neuroscience
Section of Psychiatry
University of Turin, Italy

Charles B. Nemeroff, MD, PhD
Department of Psychiatry and Behavioral Sciences
University of Miami Miller School of Medicine
Miami, FL

David J. Nutt, DM, FRCP, FRCPsych, FMedSci
Academic Unit of Psychiatry
University of Bristol
Bristol, UK

Victoria Osman-Hicks
Academic Unit of Psychiatry
University of Bristol
Bristol, UK

Mark H. Pollack, MD
Department of Psychiatry
Rush University Medical Center
Chicago, IL

John Potokar, MD, MRCPsych
Academic Unit of Psychiatry
University of Bristol
Bristol, UK

Charles F. Reynolds III, MD
Western Psychiatric Institute and Clinic
University of Pittsburgh School of Medicine
Pittsburgh, PA

Patricio Riva Posse, MD
Department of Psychiatry and Behavioral Sciences
Emory University
Atlanta, GA

Dan J. Stein, FRCPC, PhD
Department of Psychiatry and Mental Health
University of Cape Town
South Africa

Michael E. Thase, MD
Department of Psychiatry
University of Pennsylvania School of Medicine
Philadelphia, PA

Mary Ellen Trunko, MD
Department of Psychiatry
University of California-San Diego, CA

Karen Dineen Wagner, MD, PhD
Departments of Psychiatry and Behavioral Sciences and Pediatrics
University of Texas Medical Branch-Galveston, TX